AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weininger, J.
Right arrow Articles by King, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weininger, J.
Right arrow Articles by King, J. C.
Agricola
Right arrow Articles by Weininger, J.
Right arrow Articles by King, J. C.

American Journal of Clinical Nutrition, Vol 35, 1408-1416, Copyright © 1982 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Effect of oral contraceptive agents on ascorbic acid metabolism in the rhesus monkey

J Weininger and JC King

Ascorbic acid (AA) metabolism was studied in six sexually mature female rhesus monkeys with normal menstrual cycles before and during oral contraceptive administration. The animals were fed a commercial monkey stock diet (15% protein) containing no AA and given a 100 mg AA tablet daily throughout the study. After an initial adaptation period and a control period (total 8 months), combined-type oral contraceptive agents (OCAs) (50 micrograms mestranol and 1 mg norethindrone for 21 days each month) were administered to each monkey for 4 months. Serum copper and ceruloplasmin were significantly elevated during OCA treatment. There were no significant changes in plasma or leukocyte AA values during OCA use; however, urinary AA excretion decreased significantly. During the last month of the control period and the 3rd month of OCA treatment, 50 muCi of 1-14C-L-ascorbic acid were injected intravenously into each monkey. Urinary excretion of radioactivity, measured for 1 month, indicated a significantly faster AA turnover rate during the period of OCA use. These results suggest that women using OCAs may have an increased dietary requirement for AA.


This article has been cited by other articles:


Home page
 Am. J. Clin. Nutr.Home page
R. L Wolf, J. A Cauley, M. Pettinger, R. Jackson, A. Lacroix, M. S Leboff, C. E Lewis, M. C Nevitt, J. A Simon, K. L Stone, et al.
Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women's Health Initiative
Am. J. Clinical Nutrition, September 1, 2005; 82(3): 581 - 588.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
J. A. Simon and E. S. Hudes
Relation of Ascorbic Acid to Bone Mineral Density and Self-reported Fractures among US Adults
Am. J. Epidemiol., September 1, 2001; 154(5): 427 - 433.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by The American Society for Nutrition